National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Follitropin delta (Rekovelle®)

Follitropin delta (Rekovelle ®) is indicated for controlled ovarian stimulation (COS) for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle

Rapid Review Process Completed
Rapid review received 25/07/2017
Rapid review completed 15/08/2017
Rapid Review outcome Full pharmacoeconomic assessment recommended at submitted price

Reimbursement approved following new price application – February 2019.